Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression

Abstract

The insulin-like growth factor-1 receptor (IGF-1R) overexpression contributes to the development of a variety of cancers. The present study explored the role of IGF-1R in the development and progression of hepatocellular carcinoma (HCC) and the possibility of IGF-1R silencing by lentivirus-mediated RNA interference (RNAi) as a therapeutic target for HCC. We showed that IGF-1R mRNA was up-regulated in Huh7 and Hep3B cells and human HCC tissues, and that IGF-1R knockdown by RNAi led to decreased proliferation, apoptosis induction, and decreased migration and invasion of Huh7 and Hep3B cells. Further, the in vivo study indicated that IGF-1R knockdown markedly diminished the tumorigenesis and metastasis of Huh7 xenograft. Moreover, the intratumoral administration of lentivirus-IGF-1R siRNA led to significant tumor growth inhibition in an established Huh7 xenograft model. Mechanistic investigations showed that midkine was found to be the most significantly down-regulated protein in Huh7 cells with IGF-1R knockdown, and ectopic overexpression of midkine significantly rescued inhibition of Huh7 cell proliferation, migration, and invasion caused by IGF-1R suppression. Collectively, these data suggest that IGF-1R inhibition by RNAi can significantly suppress HCC growth and invasion at least partially through down-regulating midkine expression, and IGF-1R is a potential target for HCC gene therapy.

In vivo knockdown of antisense non‐coding mitochondrial RNAs by a lentiviral‐encoded shRNA inhibits melanoma tumor growth and lung colonization

“…In clinical trials, these viral vectors have displayed low immunogenicity and insertional genotoxicity (Naldini, 2015). Ongoing clinical trials with this vector are mainly focused on ex vivo transduction of hematopoietical stem cells for treatment of haematological diseases (Naldini, 2015), but there is growing interest in the development of therapeutic strategies for in vivo administration of lentivirus to solid tissues such as liver (Bie et al, 2016), retina (Dalkara, Goureau, Marazova, & Sahel, 2016) and CNS (Hutson, Foster, Moon, & Yanez-Munoz, 2014), albeit at the preclinical stage. In this work, we were able to efficiently deliver shRNA-encoding lentiviral particles to subcutaneous murine melanoma tumors by intratumoral injection.…”

Lentivirus-mediated siRNA knockdown of SPHK1 inhibits proliferation and tumorigenesis of neuroblastoma

“…The cell migration/invasion assays were performed in line with previous report. 20 In brief, Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) was added into the upper chamber of Transwell (Corning). Afterward, the wells were returned to the incubator for 2 hours and the Matrigel was allowed to solidify.…”

COPB2 suppresses cell proliferation and induces cell cycle arrest in human colon cancer by regulating cell cycle‑related proteins

“…Western blot analysis was performed as previously described ( 14 ). Briefly, at 96 h post-infection, the RKO and HCT116 cells were collected and total protein was extracted.…”